Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Halloran

Showing results (151-160 of 237) with videos related to

Pageof 24
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2012
Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsiesL G Hidalgo, J Sellares, B Sis, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 6, 2009
The early course of kidney allograft rejection: defining the time when rejection beginsG Einecke, M Mengel, L Hidalgo, et al.
Transplantation|January 1, 1991
Major histocompatibility complex antigens and murine islet allograft survivalN M Kneteman, P F Halloran, W D Sanden, et al.
Immunogenetics|January 1, 1997
Mouse class II transactivator: cDNA sequence and amino acid comparison with the human class II transactivatorT N Sims, J F Elliott, V Ramassar, et al.
Transplantation Proceedings|February 1, 1987
Prostacyclin modulates inducible major histocompatibility complex products expression in mouse kidneyJ Jephthah-Ochola, N Bernard, P F Halloran, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2007
IFN-gamma prevents early perforin-granzyme-mediated destruction of kidney allografts by inducing donor class I products in the kidneyB Sis, K S Famulski, K L Allanach, et al.
Transplantation|January 1, 1990
The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejectionP F Halloran, A Wadgymar, S Ritchie, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2016
Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated RejectionJ Reeve, J Chang, I D R Salazar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 20, 2015
The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptorsJ M Venner, L G Hidalgo, K S Famulski, et al.
Transplantation Proceedings|February 1, 1987
Graft outcome in the multiple transplant patient with a positive donor cross-match with non-current seraJ A Falk, C J Cardella, P F Halloran, et al.
Pageof 24

Showing results (151-160 of 237) with videos related to

Sort By:
Pageof 24
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2012
Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsiesL G Hidalgo, J Sellares, B Sis, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 6, 2009
The early course of kidney allograft rejection: defining the time when rejection beginsG Einecke, M Mengel, L Hidalgo, et al.
Transplantation|January 1, 1991
Major histocompatibility complex antigens and murine islet allograft survivalN M Kneteman, P F Halloran, W D Sanden, et al.
Immunogenetics|January 1, 1997
Mouse class II transactivator: cDNA sequence and amino acid comparison with the human class II transactivatorT N Sims, J F Elliott, V Ramassar, et al.
Transplantation Proceedings|February 1, 1987
Prostacyclin modulates inducible major histocompatibility complex products expression in mouse kidneyJ Jephthah-Ochola, N Bernard, P F Halloran, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 12, 2007
IFN-gamma prevents early perforin-granzyme-mediated destruction of kidney allografts by inducing donor class I products in the kidneyB Sis, K S Famulski, K L Allanach, et al.
Transplantation|January 1, 1990
The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejectionP F Halloran, A Wadgymar, S Ritchie, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2016
Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated RejectionJ Reeve, J Chang, I D R Salazar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 20, 2015
The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptorsJ M Venner, L G Hidalgo, K S Famulski, et al.
Transplantation Proceedings|February 1, 1987
Graft outcome in the multiple transplant patient with a positive donor cross-match with non-current seraJ A Falk, C J Cardella, P F Halloran, et al.
Pageof 24